These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 27639648)
21. Cellular prion protein as a therapeutic target in Alzheimer's disease. Laurén J J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943 [TBL] [Abstract][Full Text] [Related]
22. Aptamer-Induced-Dimerization Strategy Attenuates AβO Toxicity through Modulating the Trophic Activity of PrP Liu S; Li S; Lin J; Li J; Yang H J Am Chem Soc; 2022 Jun; 144(21):9264-9270. PubMed ID: 35583938 [TBL] [Abstract][Full Text] [Related]
23. Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models. Kostylev MA; Kaufman AC; Nygaard HB; Patel P; Haas LT; Gunther EC; Vortmeyer A; Strittmatter SM J Biol Chem; 2015 Jul; 290(28):17415-38. PubMed ID: 26018073 [TBL] [Abstract][Full Text] [Related]
24. Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway. Chen RJ; Chang WW; Lin YC; Cheng PL; Chen YR ACS Chem Neurosci; 2013 Sep; 4(9):1287-96. PubMed ID: 23805846 [TBL] [Abstract][Full Text] [Related]
25. Sleep deprivation regulates availability of PrP da Luz MHM; Pino JMV; Santos TG; Antunes HKM; Martins VR; de Souza AAL; Torquato RJS; Lee KS J Neurochem; 2020 May; 153(3):377-389. PubMed ID: 31950499 [TBL] [Abstract][Full Text] [Related]
26. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity. Peters C; Espinoza MP; Gallegos S; Opazo C; Aguayo LG Neurobiol Aging; 2015 Mar; 36(3):1369-77. PubMed ID: 25599875 [TBL] [Abstract][Full Text] [Related]
27. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease. Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882 [TBL] [Abstract][Full Text] [Related]
28. Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein. Rubenstein R; Chang B; Grinkina N; Drummond E; Davies P; Ruditzky M; Sharma D; Wang K; Wisniewski T Acta Neuropathol Commun; 2017 Apr; 5(1):30. PubMed ID: 28420443 [TBL] [Abstract][Full Text] [Related]
29. Anti-PrP Cox TO; Gunther EC; Brody AH; Chiasseu MT; Stoner A; Smith LM; Haas LT; Hammersley J; Rees G; Dosanjh B; Groves M; Gardener M; Dobson C; Vaughan T; Chessell I; Billinton A; Strittmatter SM Ann Clin Transl Neurol; 2019 Mar; 6(3):554-574. PubMed ID: 30911579 [TBL] [Abstract][Full Text] [Related]
30. Cellular prion protein acts as mediator of amyloid beta uptake by caveolin-1 causing cellular dysfunctions in vitro and in vivo. da Silva Correia A; Schmitz M; Fischer AL; da Silva Correia S; Simonetti FL; Saher G; Goya-Maldonado R; Arora AS; Fischer A; Outeiro TF; Zerr I Alzheimers Dement; 2024 Oct; 20(10):6776-6792. PubMed ID: 39212313 [TBL] [Abstract][Full Text] [Related]
31. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475 [TBL] [Abstract][Full Text] [Related]
32. cAMP-induced decrease in cell-surface laminin receptor and cellular prion protein attenuates amyloid-β uptake and amyloid-β-induced neuronal cell death. Gopalakrishna R; Lin CY; Oh A; Le C; Yang S; Hicks A; Kindy MS; Mack WJ; Bhat NR FEBS Lett; 2022 Nov; 596(22):2914-2927. PubMed ID: 35971617 [TBL] [Abstract][Full Text] [Related]
33. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity. Smith LM; Strittmatter SM Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601 [TBL] [Abstract][Full Text] [Related]
34. Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Nygaard HB; Strittmatter SM Arch Neurol; 2009 Nov; 66(11):1325-8. PubMed ID: 19901162 [TBL] [Abstract][Full Text] [Related]
35. A label-free electrical impedimetric biosensor for the specific detection of Alzheimer's amyloid-beta oligomers. Rushworth JV; Ahmed A; Griffiths HH; Pollock NM; Hooper NM; Millner PA Biosens Bioelectron; 2014 Jun; 56():83-90. PubMed ID: 24480125 [TBL] [Abstract][Full Text] [Related]
36. The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease. Larson M; Sherman MA; Amar F; Nuvolone M; Schneider JA; Bennett DA; Aguzzi A; Lesné SE J Neurosci; 2012 Nov; 32(47):16857-71a. PubMed ID: 23175838 [TBL] [Abstract][Full Text] [Related]
37. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates. Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510 [TBL] [Abstract][Full Text] [Related]